Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gutong patch
- Development stage
- Unknown
- Lead developer
- Peking Union Medical College Hospital
- Modality
- Small Molecules
- Administration
- Topical, Transdermal
01
Overview
Gutong patch is a Traditional Chinese Medicine (TCM) topical analgesic developed by Peking Union Medical College Hospital and manufactured by Guilin Sanjin Pharmaceutical. It is formulated as a transdermal patch containing a complex mixture of herbal extracts, including *Caulis Spatholobi*, *Radix Clematidis*, and *Rhizoma Drynariae*. The patch is primarily indicated for the treatment of joint pain associated with osteoarthritis, cervical spondylosis, and lumbar muscle strain. Its therapeutic effect is attributed to the synergistic action of its phytochemical constituents, which promote local blood circulation, reduce inflammation by inhibiting pro-inflammatory cytokines and enzymes like COX-2, and alleviate pain through the dispelling of wind and cold according to TCM principles.
- Brand names
- Sanjin Gutong PatchGutong Tiegao
- Other names
- 骨通贴膏
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Gutong patch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gutong patch.